Bonebridge approved for children from 5 years

Market

© MED-EL

MED-EL‘s Bonebridge active bone conduction implant is now also approved for children from 5 years of age. After two years of experience with the bone conduction implant, Prof. Georg Sprinzl sees the Bonebridge as a promising solution for young patients. Sprinzl is Head of the University Clinic for Ear, Nose and Throat Medicine at the Karl Landsteiner University of Health Sciences, Landesklinikum St. Pölten, west of Vienna. “Thanks to Bonebridge we were already able to give a good portion of quality of life back to many people with conductive hearing loss. The success rate is very high. It’s an important step that we can now also treat children with this technology,” he says.

One of the benefits of the Bonebridge in child care is its transcutaneous intact skin technology, enabling the implant to be placed entirely under the skin surface. In this way, the protective function of the skin is completely preserved. “This factor is particularly important in children because there is no risk of infection from external sources,” explains Prof. Sprinzl. It also plays an important role in esthetics as the implant is located entirely out of sight under the intact skin. Because of the small size of the audio processor, it is barely visible even in children and the ear canal remains completely open.

Source: MED-EL

D.K.